Prevention of neointima formation by taurine ingestion after carotid balloon injury

Vascular Pharmacology

Volumn 53, Issue 3-4, 2010, Pages 177-184

  Murakami, Shigeru ^a   Sakurai, Takanobu ^a   Toda, Yoshihisa ^a   Morito, Akihisa ^a   Sakono, Masanobu ^b   Fukuda, Nobuhiro ^b  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Balloon injury; Oxidative stress; Restenosis; Smooth muscle cells; Taurine

Indexed keywords

SUPEROXIDE; TAURINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERIAL WALL THICKNESS; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; CAROTID ARTERY INJURY; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; MALE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; BALLOON DILATION; CAROTID ARTERY INJURIES; CAROTID ARTERY, COMMON; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; MALE; MUSCLE, SMOOTH, VASCULAR; NEOINTIMA; RATS; RATS, WISTAR; TAURINE; TUMOR NECROSIS FACTOR-ALPHA; TUNICA INTIMA; TUNICA MEDIA;

EID: 77956185664     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2010.07.003     Document Type: Article

References (46)

1. Azevedo L.C., Pedro M.A., Souza L.C., de Souza H.P., Janiszewski M., da Luz P.L., Laurindo F.R. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc. Res. 2000, 47:436-445.
2. Babior B.M. Phagocytes and oxidative stress. Am. J. Med. 2000, 109:33-44.
3. Balkan J., Kanbagli O., Hatipoglu A., Kucuk M., Cevikbas U., Aykac-Toker G., Uysal M. Improving effect of dietary taurine supplementation on the oxidative stress and lipid levels in the plasma, liver and aorta of rabbits fed on a high-cholesterol diet. Biosci. Biotechnol. Biochem. 2002, 66:1755-1758.
4. Davis C., Fischer J., Ley K., Sarembock I.J. The role of inflammation in vascular injury and repair. J. Thromb. Haemost. 2003, 1:1699-1709.
5. Fukuda K., Hirai Y., Yoshida H., Nakajima T., Usui T. Free amino acid content of lymphocytes and granulocytes compared. Clin. Chem. 1982, 28:1758-1761.
6. Grisham M.B., Jefferson M.M., Melton D.F., Thomas E.L. Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J. Biol. Chem. 1984, 259:10404-10413.
7. Hay C., Micko C., Prescott M.F., Liau G., Robinson K., De Leon H. Differential cell cycle progression patterns of infiltrating leukocytes and resident cells after balloon injury of the rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1948-1954.
8. Huxtable R.J. Physiological actions of taurine. Physiol. Rev. 1992, 72:101-163.
9. Ishizaka N., Kurokawa K., Taguchi J., Miki K., Ohno M. Inhibitory effect of a single local probucol administration on neointimal formation in balloon-injured rat carotid artery. Atherosclerosis 1995, 118:53-56.
10. Ito T., Kimura Y., Uozumi Y., Takai M., Muraoka S., Matsuda T., Ueki K., Yoshiyama M., Ikawa M., Okabe M., Schaffer S.W., Fujio Y., Azuma J. Taurine depletion by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J. Mol. Cell. Cardiol. 2008, 44:927-937.
11. Kempf E., Ebel A., Wendling S., Bollack C., Mandel P. The distribution of free amino acids in arterial walls and their modifications during aging. Rev. Eur. Étud. Clin. Biol. 1970, 15:857-861.
12. Kim C., Park E., Quinn M.R., Schuller-Levis G. The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-α in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 1996, 34:89-95.
13. Kingston R., Kelly C.J., Murray P. The therapeutic role of taurine in ischaemia-reperfusion injury. Curr. Pharm. Des. 2004, 10:2401-2410.
14. Kondo Y., Toda Y., Kitajima H., Oda H., Nagate T., Kameo K., Murakami S. Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice. Clin. Exp. Pharmacol. Physiol. 2001, 28:809-815.
15. Marcinkiewicz J., Grabowska A., Bereta J., Stelmaszynska T. Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J. Leukoc. Biol. 1995, 58:667-674.
16. Marcinkiewicz J., Grabowska A., Bereta J., Bryniarski K., Nowak B. Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 1998, 40:27-38.
17. Martinez V., Mitjans M., Vinardell M.P. TNF α measurement in rat and human whole blood as an in vitro method to assay pyrogens and its inhibition by dexamethasone and erythromycin. J. Pharm. Sci. 2004, 93:2718-2723.
18. Mass H., Pirazzi B., Gonzalez P., Collazo V., Fitzovich D., Avakian E. N-acetylcysteine diminishes injury induced by balloon angioplasty of the carotid artery in rabbits. Biochem. Biophys. Res. Commun. 1995, 215:613-618.
19. Matsushima Y., Sekine T., Kondo Y., Sakurai T., Kameo K., Tachibana M., Murakami S. Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidaemic mice. Clin. Exp. Pharmacol. Physiol. 2003, 30:295-299.
20. Murakami S., Yamagishi I., Asami Y., Ohta Y., Nara Y., Yamori Y. Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 1996, 52:303-313.
21. Murakami S., Toda Y., Seki T., Munetomo E., Kondo Y., Sakurai T., Furukawa Y., Matsuyama M., Nagate T., Hosokawa N., Nagata K. Heat shock protein (HSP) 47 and collagen are upregulated during neointimal formation in the balloon-injured rat carotid artery. Atherosclerosis 2001, 157:361-368.
22. Murakami S., Kondo Y., Sakurai T., Kitajima H., Nagate T. Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 2002, 163:79-87.
23. Nakamura T., Ogasawara M., Koyama I., Nemoto M., Yoshida T. The protective effect of taurine on the biomembrane against damage produced by oxygen radicals. Biol. Pharm. Bull. 1993, 16:970-972.
24. Napoli C., deNigris C., Palinski W. Multiple role of reactive oxygen species in the arterial wall. J. Cell. Biochem. 2001, 82:674-682.
25. Nara Y., Yamori Y., Lovenberg W. Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem. Pharmacol. 1978, 27:297-306.
26. Nonaka H., Tsujino T., Watari Y., Emoto N., Yokoyama M. Taurine prevents the decrease in expression and secretion of extracellular superoxide dismutase induced by homocysteine: amelioration of homocysteine-induced endoplasmic reticulum stress by taurine. Circulation 2001, 104:1165-1170.
27. Okamoto E., Couse T., De Leon H., Vinten-Johanson J., Goodman R.B., Scott N.A., Wilcox J.N. Perivascular inflammation after balloon angioplasty of porcine coronary arteries. Circulation 2001, 104:2228-2235.
28. Oudit G.Y., Trivieri M.G., Khaper N., Husain T., Wilson G.J., Liu P., Sole M.J., Backx P.H. Taurine supplementation reduces oxidative stress and improves cardiovascular function in an iron-overload murine model. Circulation 2004, 109:1877-1885.
29. Park S.J., Kim H.S., Yang H.M., Park K.W., Youn S.W., Jeon S.I., Kim D.H., Koo B.K., Chae I.H., Choi D.J., Oh B.H., Lee M.M., Park Y.B. Thalidomide as a potent inhibitor of neointimal hyperplasia after balloon injury in rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 2004, 24:885-891.
30. Petty M.A., Kintz J., DiFrancesco G.F. The effects of taurine on atherosclerosis development in cholesterol-fed rabbits. Eur. J. Pharmacol. 1990, 180:119-127.
31. Rajagopalan S., Kurz S., Münzel T., Tarpey M., Freeman B.A., Griendling K.K., Harrison D.G. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alteration of vasomotor tone. J. Clin. Invest. 1996, 97:1916-1923.
32. Sakurai T., Miki T., Li H.P., Miyatake A. Colocalization of taurine and glial fibrillary acidic protein immunoreactivity in mouse hippocampus induced by short-term ethanol exposure. Brain Res. 2003, 959:160-164.
33. Schuller-Levis G.B., Park E. Taurine and its chloramine: modulators of immunity. Neurochem. Res. 2004, 29:117-126.
34. Shi Y., Niculescu R., Wang D., Patel S., Davenpeck K.L., Zalewski A. Increased NAD(P)H oxidase and reactive oxygen species in coronary arteries after balloon injury. Arterioscler. Thromb. Vasc. Biol. 2001, 21:739-745.
35. Szöcs K., Lassegue B., Sorescu D., Hilenski L.L., Valppu L., Couse T.L., Wilcox J.N., Quinn M.T., Lambeth J.D., Griendling K.K. Upregulation of Nox-based NAD(P)H oxidases in restenosis after carotid injury. Arterioscler. Thromb. Vasc. Biol. 2002, 22:21-27.
36. Tanaka H., Sukhova G., Schwartz D., Libby P. Proliferating arterial smooth muscle cells after balloon injury express TNF-α but not interleukin-1 or basic fibroblast growth factor. Arterioscler. Thromb. Vasc. Biol. 1996, 16:12-18.
37. Trachtman H., Futterweit S., Maesaka J., Ma C., Valderrame E., Fuchs A., Tarectecan A.A., Rao P.S., Sturman J.A., Boles T.H. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am. J. Physiol. 1995, 269(3 Pt 2):F429-F438.
38. Turnell D.C., Cooper J.D. Rapid assay for amino acids in serum or urine by pre-column derivatization and reverse-phase liquid chromatography. Clin. Chem. 1982, 28:527-531.
39. Warskulat U., Flogel U., Jacoby C., Hartwig H.G., Thewissen M., Merx M.W., Molojavyi A., Heller-Stilb B., Schrader J., Häussinger D. Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J. 2004, 18:577-579.
40. Warskulat U., Borsch E., Reinehr R., Heller-Stilb B., Monnighoff I., Buchczyk D., Donner M., Flogel U., Kappert G., Soboll S., Beer S., Pfeffer K., Marschall H.U., Gabrielsen M., Amiry-Moghaddam M., Ottersen O.P., Dienes H.P., Häussinger D. Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB J. 2006, 20:574-576.
41. Waters E., Wang J.H., Redmond H.P., Wu Q.D., Kay E., Bouchier-Hayes D. Role of taurine in preventing acetaminophen-induced hepatic injury in the rat. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 280:G1274-G1279.
42. Xing D., Miller A., Novak L., Rocha R., Chen Y.F., Oparil S. Estradiol and progestins differentially modulate leukocyte infiltration after vascular injury. Circulation 2004, 109:234-241.
43. Yamori Y., Liu L., Ikeda K., Miura A., Mizushima S., Miki T., Nara Y. Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens. Res. 2001, 24:453-457.
44. Zeymer U., Fishbein M.C., Forrester J.S., Cercek B. Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling. Am. J. Pathol. 1992, 141:685-690.
45. Zhang X., Tenner T.E., Lombardini J.B. Inhibition of rat vascular smooth muscle cell proliferation by taurine and taurine analogues. Biochem. Pharmacol. 1999, 57:1331-1339.
46. Zhang M., Izumi I., Kagamimori S., Sokejima S., Yamagami T., Liu Z., Qi B. Role of taurine supplementation to prevent exercise-induced oxidative stress in healthy young men. Amino Acids 2004, 26:203-207.